Consider Pros and Cons of Tirzepatide for Obesity
August 2025
Tirzepatide (Zepbound) will be a new option for obesity...now that it’s available in Canada to promote weight loss in adults.
Tirzepatide is the same ingredient in Mounjaro for type 2 diabetes. It works similarly to semaglutide (Wegovy), but it’s a dual agonist...at both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors.
These meds increase satiety and slow gastric emptying...which may lead to weight loss in people with or without diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive